All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · promoting growth and development in very low birth weight infants receiving human milk
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · feed interruption while monitoring gastric residual
Summary of findings table ‐ Quality and volume of gastric residual showed no clear difference in all‐cause mortality before hospital discharge compared with quality of gastric residual alone (low certainty).
1 finding from 1 review
In‐hospital mortality · promoting growth and development in very low birth weight infants receiving human milk
It is very uncertain whether targeted individualized changes in‐hospital mortality compared with standard non‐individualized fortification (very low certainty).
1 finding from 1 review
Infant Mortality at 24 months among those uninfected at birth · Breastfeeding infants of HIV‐infected mothers
An extended NVP plus ZDV dual regimen administered to infants for 14… showed no clear difference in infant Mortality at 24 months among those uninfected at birth compared with an extended NVP regimen administered to infants (moderate certainty).
1 finding from 1 review
Infant Mortality at 9 months among those whose HIV diagnostic testing was negative within 48 hours of birth · Breastfeeding infants of HIV‐infected mothers
An extended NVP plus ZDV dual regimen administered to infants for 14… showed no clear difference in infant Mortality at 9 months among those whose HIV diagnostic… compared with an extended NVP regimen administered to infants (moderate certainty).
1 finding from 1 review
Intervention not reported
Mortality · antiretroviral‐naïve individuals
The intervention showed no clear difference in mortality (moderate certainty).
1 finding from 1 review
All‐cause mortality · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
It is very uncertain whether d4T changes mortality compared with AZT (very low certainty).
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether more frequent (less than eight hours) changes mortality (at the end of compared with less frequent (eight hours or greater) monitoring of gastric… (very low certainty).
1 finding from 1 review
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality (at the end of · adults receiving EN via nasogastric or gastrostomy tube
It is very uncertain whether no monitoring changes mortality (at the end of compared with frequent monitoring (12 hours or less) of gastric residual volume (very low certainty).
1 finding from 1 review
Intervention not reported
Treatment related mortality · individuals with HL
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · people with antiphospholipid antibodies and no history of thrombosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients receiving PD
Angiotensin‐converting enzyme inhibitors (ACEi) showed no clear difference in mortality compared with conventional therapy (moderate certainty).
1 finding from 1 review
Intervention not reported
CRC Mortality ‐ Flexible sigmoidoscopy · Asymptomatic individuals
The intervention leads to lower CRC Mortality ‐ Flexible sigmoidoscopy (high certainty).
1 finding from 1 review